Clinical Grade Wearables Market Size & Share 2026-2035

Clinical Grade Wearables Market Size

The global clinical grade wearables market was estimated at USD 137.7 billion in 2025. The market is expected to grow from USD 158.2 billion in 2026 to USD 617.9 billion in 2035, at a CAGR of 16.3% during the forecast period, according to the latest report published by Global Market Insights Inc. The market is driven by numerous factors, such as increasing awareness about physical fitness, wearable devices among the population in developing countries, and growing prevalence of chronic diseases globally.

The clinical grade wearables market comprises medical grade, sensor enabled wearable devices designed to continuously or periodically monitor physiological parameters for clinical diagnosis, disease management, treatment monitoring, and remote patient care. These devices are clinically validated and comply with regulatory standards to ensure high accuracy, safety, and reliability. They enable real time health data collection, facilitate informed clinical decision making, support remote patient monitoring, and improve patient outcomes by enhancing disease detection, treatment adherence, and personalised healthcare delivery.

The clinical grade wearables market is witnessing increasing competitive activity driven by continuous innovation and expanding product portfolios. iRhythm Technologies, Boston Scientific, BioIntelliSense, Withings, and Omron Healthcare are among the leading players operating in the market. These companies primarily focus on product innovation, research and development, regulatory compliance, strategic collaborations, and geographic expansion to maintain their competitive advantage.

The market has increased from USD 93.8 billion in 2022 and reached USD 120.1 billion in 2024, with a historic growth rate of 13.2%. The growing prevalence of chronic diseases is a key factor driving the growth of the clinical grade wearables market, as it is increasing the demand for continuous health monitoring and remote patient management solutions. Chronic conditions such as diabetes, cardiovascular diseases, hypertension, and respiratory disorders require regular monitoring to enable timely clinical intervention and improve overall disease management. According to the International Diabetes Federation, the global number of adults living with diabetes is projected to increase from 589 million in 2024 to approximately 853 million by 2050, representing an increase of nearly 46%. Similarly, the World Health Organization estimates that approximately 1.28 billion adults aged 30–79 years worldwide are living with hypertension, with a significant proportion remaining undiagnosed or inadequately controlled. As the burden of these chronic conditions continues to rise, healthcare providers are increasingly adopting clinical grade wearable technologies to support real-time monitoring, early detection of health risks, and more effective disease management. The growing deployment of these wearables across both clinical and home healthcare settings is enhancing patient monitoring capabilities, improving healthcare efficiency, and creating sustained growth opportunities for the clinical grade wearables market.

Additionally, increasing awareness about physical fitness and wearable devices among the population in developing countries is emerging as a significant driver of the clinical grade wearables market. Rising health consciousness, growing adoption of preventive healthcare practices, and increasing concerns regarding lifestyle-related diseases are encouraging individuals to actively monitor their health and fitness parameters. The widespread use of smartphones, expanding internet connectivity, and greater access to digital health applications have further increased consumer familiarity with wearable technologies. As consumers become more aware of the benefits of tracking vital signs, physical activity, sleep patterns, and overall wellness, the demand for advanced wearable devices is increasing. Additionally, government health initiatives, public health campaigns, and the growing influence of social media and fitness communities are promoting the adoption of health-monitoring solutions. This increasing acceptance of wearable technologies is accelerating their integration into both personal wellness and clinical care settings, thereby supporting the sustained growth of the market.

Clinical Grade Wearables Market Trends

• Technological advancements in clinical grade wearables play a critical role in driving market growth by improving the accuracy of physiological monitoring, enabling continuous patient surveillance, and supporting timely clinical decision making across hospital, outpatient, and home healthcare settings.
• Advanced clinical grade wearables are increasingly being developed with sophisticated sensing technologies, including electrocardiography (ECG), photoplethysmography (PPG), continuous glucose monitoring (CGM), pulse oximetry (SpO₂), blood pressure, respiratory rate, temperature, and motion sensors, enabling continuous measurement of multiple physiological parameters. These devices are further integrated with wireless connectivity, cloud-based data platforms, advanced signal-processing algorithms, and interoperable digital health systems, facilitating real time data transmission, remote patient monitoring, and enhanced clinical accuracy. Continuous advancements in device miniaturization, battery efficiency, sensor precision, and wearable comfort are further improving long-term usability and clinical performance.
• These technological advancements significantly improve the early detection and management of chronic and acute medical conditions by enabling continuous monitoring beyond conventional healthcare settings. Additionally, real time data sharing, automated clinical alerts, interoperability with electronic health records (EHRs), and integration with telehealth platforms enable healthcare professionals to monitor patients remotely, support timely medical intervention, and optimize clinical workflows. The ability to provide continuous, clinically validated health data also enhances patient engagement, treatment adherence, and personalized disease management while reducing unnecessary hospital admissions and improving overall healthcare efficiency.
• For instance, products such as Abbott Laboratories’ Freestyle Libre continuous glucose monitoring (CGM) platform are contributing significantly to the growth of the clinical-grade wearables market by enabling real-time and continuous monitoring of glucose levels without the need for frequent finger-prick testing. These advanced wearable solutions improve disease management, support early clinical intervention, enhance patient engagement, and facilitate remote monitoring by healthcare providers. As healthcare systems increasingly focus on preventive care, personalized treatment, and chronic disease management, the adoption of clinically validated wearable devices continues to rise, thereby driving the expansion of the clinical-grade wearables market.
• Collectively, these technological innovations demonstrate the industry's strong focus on developing clinically validated, connected, and patient centric wearable solutions that improve monitoring accuracy, enhance clinical outcomes, and expand access to remote healthcare services. Consequently, continued advancements in sensor technologies, connectivity, and wearable device capabilities are expected to remain a key factor supporting the sustained growth of the global market.

Clinical Grade Wearables Market Analysis

Based on devices, the clinical grade wearables market is segmented into activity/fitness monitors, diabetes devices, cardiac monitors, neurological monitors, respiratory monitors, body & temperature monitors, in-ear devices and other devices. The activity/fitness monitors segment accounted for a dominant market share of 25% in 2025.

• The activity/fitness monitors segment represented the dominating category in the clinical-grade wearables market, driven by increasing awareness of preventive healthcare, fitness tracking, and continuous health assessment. These devices are widely adopted due to their ability to monitor key physiological parameters, including activity levels, heart rate, and sleep patterns, while supporting personalized health management.
• Furthermore, advancements in sensor technologies, connectivity, and integration with digital health platforms have enhanced their functionality, strengthening their adoption across consumer and healthcare applications and maintaining their leading position in the market.
• The diabetes devices segment is projected to expand at the CAGR of 16.9% to reach USD 103.9 billion by 2035. The segment includes continuous glucose monitoring (CGM) systems and other wearable solutions designed to support diabetes management through continuous glucose tracking. Rising diabetes prevalence, increasing demand for minimally invasive monitoring solutions, and advancements in sensor accuracy are driving adoption.
• Furthermore, the growing adoption of wearable diabetes management devices in both clinical and home healthcare settings is creating significant opportunities for market expansion. Continuous glucose monitoring systems enable healthcare providers and patients to access real-time glucose data, supporting personalized treatment decisions and better glycemic control. The increasing shift toward remote patient monitoring, coupled with rising awareness of the long-term complications associated with uncontrolled diabetes, is further accelerating demand for these devices.
• The cardiac monitors segment accounted for 13.6% market share in 2025 and is projected to grow at a CAGR of 16.1%. The segment comprises wearable ECG patches and cardiac monitoring devices that enable continuous assessment of heart rhythm and cardiovascular parameters. Growing prevalence of cardiovascular disorders, increasing demand for early diagnosis, and adoption of remote cardiac monitoring solutions are supporting segment expansion. Integration of AI-based analytics and cloud connectivity is further enhancing clinical utility.
• The respiratory monitors segment accounted for significant revenue in 2025 and is projected to expand at a CAGR of 16.5% over the forecast period. These wearable devices are designed to continuously track critical respiratory parameters, including oxygen saturation levels, respiratory rate, and breathing patterns, enabling timely detection of health changes. The segment is witnessing strong growth due to the increasing burden of respiratory conditions such as COPD, asthma, and sleep apnea. Rising adoption of home-based healthcare services and the growing need for continuous patient monitoring are further supporting demand. In addition, healthcare providers are increasingly utilizing remote monitoring technologies to improve patient outcomes and reduce hospital admissions. These factors are collectively contributing to the expansion of the respiratory monitoring devices segment.
• The body and temperature monitors segment accounted for significant revenue in 2025 and is projected to expand at a CAGR of 16.3% over the forecast period. This segment includes wearable devices designed for monitoring body temperature and other physiological parameters. Increasing demand for continuous health assessment, infection monitoring, and connected healthcare solutions is supporting adoption across clinical and home healthcare settings.
• The in-ear devices segment accounted for significant revenue in 2025 and is projected to expand at a CAGR of 15.9% over the forecast period. Ear-worn devices are increasingly being utilized to monitor body temperature and other physiological parameters, enabling continuous health assessment in a convenient and non-invasive manner. Growing demand for real-time health tracking, early detection of infections, and preventive healthcare is driving adoption of these devices. Their ability to seamlessly collect and transmit health data supports remote patient monitoring and connected care initiatives. In addition, increasing use across home healthcare and clinical settings is expanding their application scope. These factors are collectively contributing to the growth of the ear-worn monitoring devices segment.
• The neurological monitors segment accounted for significant revenue in 2025 and is projected to expand at a CAGR of 15.7% over the forecast period.  Neurological monitoring devices are gaining increased adoption for applications such as seizure detection, brain activity assessment, and continuous neurological health tracking. Growing awareness of neurological disorders and the need for timely intervention are supporting demand for these advanced wearable solutions. Technological advancements in biosensors, artificial intelligence, and real-time data analytics are enhancing monitoring accuracy and clinical utility. In addition, the expanding use of remote patient monitoring and connected healthcare platforms is improving access to neurological care. These factors are collectively contributing to the growth of the neurological monitoring devices segment.

Based on application, the clinical grade wearables market is segmented into cardiac health, obesity control, diabetes care, fitness monitoring, sleep tracking, and other applications. The fitness monitoring segment represented the dominating application category in the market, accounting for 23% market share in 2025.

• Fitness monitoring devices are witnessing strong adoption as individuals increasingly focus on preventive healthcare, physical fitness, and overall well-being. These wearable solutions enable continuous tracking of physical activity, heart rate, sleep patterns, and other health metrics, supporting personalized health management. Growing awareness of lifestyle-related diseases such as obesity, diabetes, and cardiovascular disorders is encouraging consumers to actively monitor their health. In addition, the rising penetration of digital health technologies and connected wellness platforms is further accelerating adoption. These factors are collectively contributing to the growth of the fitness monitoring devices segment.

• Furthermore, advancements in sensor technologies, artificial intelligence, and connected healthcare platforms have enhanced the accuracy and functionality of fitness monitoring devices, enabling better health insights and integration with healthcare ecosystems. The growing emphasis on preventive care, remote monitoring, and proactive health management continues to strengthen the adoption of fitness monitoring solutions, reinforcing their leading position within the clinical-grade wearables market.
• The obesity control segment is projected to expand at a CAGR of 16.4% to reach USD 122 billion by 2035. Weight management wearables are gaining significant traction as the prevalence of obesity and related health conditions continues to increase globally. These devices support continuous monitoring of physical activity, calorie expenditure, sleep patterns, and other health metrics, helping users achieve personalized weight management goals. Growing emphasis on preventive healthcare and lifestyle modification programs is encouraging the adoption of wearable solutions that promote healthier behaviours and long-term wellness. In addition, the integration of these devices with digital health applications, mobile platforms, and wellness ecosystems enables more effective tracking and personalized guidance. These factors are collectively contributing to the growth of the weight management wearables segment.
• The diabetes care segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 16.8% over the forecast period.  Diabetes monitoring devices are experiencing strong growth due to the increasing global burden of diabetes and the growing need for effective disease management solutions. These wearable devices enable continuous glucose tracking, allowing patients and healthcare providers to make informed treatment decisions and improve glycemic control. Rising demand for minimally invasive and real-time monitoring technologies is further accelerating adoption. Advancements in sensor performance, connectivity, and data analytics are enhancing device accuracy and user experience. In addition, integration with digital healthcare platforms and remote patient monitoring systems is supporting personalized care and improving clinical outcomes. These factors are collectively contributing to the growth of the diabetes monitoring devices segment.
• The cardiac health segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 15.7% over the forecast period. Cardiac monitoring devices are witnessing increasing adoption owing to the rising prevalence of cardiovascular diseases and the growing need for continuous heart health assessment. These wearable solutions enable real-time monitoring of heart rhythm, heart rate, and other critical cardiovascular parameters, supporting early detection of potential cardiac abnormalities. The increasing demand for remote patient monitoring and preventive cardiac care is further driving market growth.
• Additionally, advancements in artificial intelligence, biosensor technologies, and connected healthcare platforms are enhancing diagnostic accuracy and clinical decision-making. These factors are collectively contributing to the growth of the cardiac monitoring devices segment.
• The sleep tracking segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 15.9% over the forecast period. Sleep monitoring devices are gaining increasing adoption due to growing awareness of the importance of sleep health and the rising prevalence of sleep-related disorders such as insomnia, sleep apnea, and circadian rhythm disturbances. These wearable solutions continuously track sleep duration, quality, and sleep stages, providing valuable insights into overall health and wellness. The increasing focus on preventive healthcare and early detection of sleep abnormalities is supporting demand across both clinical and consumer settings. In addition, advancements in sensor technologies and integration with digital health platforms are enhancing monitoring accuracy and user engagement. These factors are collectively contributing to the growth of the sleep monitoring devices segment.

Based on end use, the global clinical-grade wearables market is segmented into hospitals, home care settings, and other end users. The home care setting segment represented the dominating end use category in the clinical grade wearables market, accounting for 60.2% market share in 2025.

• Home care setting is witnessing increasing adoption of clinical-grade wearables due to the growing demand for continuous patient monitoring and personalized care outside traditional healthcare facilities. These wearable devices enable real-time tracking of vital signs and health parameters, supporting effective chronic disease management and timely clinical intervention. Increasing adoption of remote patient monitoring programs and the rising preference for home-based healthcare are accelerating utilization.
• Moreover, the need to reduce hospital admissions, lower healthcare costs, and improve patient convenience is further driving demand. These factors are collectively contributing to the growth of the home healthcare segment in the clinical-grade wearables market. Furthermore, advancements in connected health platforms and digital monitoring solutions are enabling effective patient management outside traditional healthcare facilities, reinforcing the dominance of this segment.
• The hospitals segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 16.5% over the forecast period. Hospitals represent a key end-user category due to the increasing adoption of clinical-grade wearables for inpatient monitoring, post discharge care, and management of complex health conditions. The availability of advanced healthcare infrastructure, trained medical professionals, and integration of wearable data with hospital information systems supports the adoption of these devices. Growing emphasis on improving patient outcomes, early intervention, and efficient healthcare delivery continues to drive the use of clinical-grade wearables across hospital settings.

North America Clinical Grade Wearables Market

The North America market accounted for the leading regional share of 40.4% in 2025 and is anticipated to demonstrate significant growth over the forecast period.

• The U.S. market was valued at USD 34.4 billion and USD 38.5 billion in 2022 and 2023, respectively. The market size reached USD 50.3 billion in 2025, growing from USD 43.9 billion in 2024, and is anticipated to grow at a CAGR of 16.2% from 2026 to 2035.
• The growing prevalence of chronic diseases is a major factor driving the North America clinical-grade wearables market. The increasing burden of conditions such as diabetes, cardiovascular diseases, hypertension, and respiratory disorders has created a strong demand for continuous health monitoring and proactive disease management solutions. Clinical-grade wearables enable real-time tracking of vital health parameters, allowing healthcare providers to detect potential complications early and improve patient outcomes. As healthcare systems increasingly focus on preventive care and remote patient monitoring, the adoption of wearable technologies continues to expand across the region.
• Diabetes remains one of the most significant chronic health concerns in North America, further supporting market growth. According to the American Diabetes Association, approximately 40.1 million people in the U.S. were living with diagnosed or undiagnosed diabetes in 2023. This growing patient population is increasing the need for advanced wearable devices such as continuous glucose monitoring systems that facilitate continuous health tracking and personalized disease management. Consequently, the rising prevalence of chronic diseases is expected to drive sustained demand for clinical-grade wearables across North America.

Europe Clinical Grade Wearables Market

Europe market accounted for USD 30.1 billion in 2025 and is anticipated to show lucrative growth over the forecast period.

• The Europe clinical-grade wearables market is being significantly driven by continuous technological advancements in wearable devices. Innovations in biosensors, miniaturization, wireless connectivity, and real-time data analytics are enhancing the accuracy, reliability, and clinical utility of wearable monitoring solutions. These advancements are enabling healthcare providers to monitor patients more effectively and support timely clinical decision-making.
• Furthermore, the integration of artificial intelligence, cloud-based platforms, and advanced health tracking capabilities is expanding the applications of clinical-grade wearables across chronic disease management, remote patient monitoring, and preventive healthcare. The increasing availability of sophisticated and user-friendly wearable devices is encouraging adoption across hospitals, outpatient facilities, and home healthcare settings, thereby supporting the growth of the Europe clinical-grade wearables market.

Asia Pacific Clinical Grade Wearables Market

The Asia Pacific region is projected to show a lucrative growth of about 17% during the forecast period.

• The Asia Pacific market growth is supported by rising disposable income and increasing healthcare expenditure across emerging economies. Improving economic conditions are enabling greater access to advanced healthcare technologies, while higher healthcare spending is accelerating the adoption of clinical-grade wearable devices for continuous patient monitoring and disease management. In addition, growing health awareness and expanding healthcare infrastructure are encouraging the utilization of wearable solutions across both clinical and home healthcare settings, contributing to sustained regional market growth.
• Furthermore, the rising prevalence of chronic diseases, including diabetes, cardiovascular disorders, and obesity, is contributing to the increasing adoption of clinically validated wearable devices across Asia Pacific. The growing disease burden is creating demand for continuous monitoring solutions such as glucose monitoring systems, cardiac monitors, and multiparameter biosensors that support effective disease management and improved patient outcomes. In addition, increasing disposable income, improving healthcare access, and rising investments in healthcare technology are further supporting the expansion of clinical-grade wearables across the region.

Latin America Clinical Grade Wearables Market

• The Latin America market is experiencing growth due to the increasing prevalence of chronic diseases across the region. Conditions such as diabetes, cardiovascular diseases, hypertension, and respiratory disorders are creating a greater need for continuous health monitoring and effective disease management solutions. Clinical-grade wearables enable real-time tracking of critical health parameters, supporting early intervention and improved patient outcomes.
• Moreover, growing healthcare awareness and the increasing focus on preventive care are encouraging the adoption of wearable monitoring technologies among both patients and healthcare providers. The rising demand for remote patient monitoring, coupled with efforts to improve access to healthcare services, is accelerating the utilization of clinical-grade wearables across hospitals, clinics, and home healthcare settings, contributing to sustained market growth in Latin America.

Middle East and Africa Clinical Grade Wearables Market

• The Middle East and Africa market is benefiting from increasing awareness about physical fitness and wearable devices among the population. Growing health consciousness, rising adoption of preventive healthcare practices, and increasing concerns regarding lifestyle-related conditions such as obesity, diabetes, and cardiovascular diseases are encouraging individuals to actively monitor their health and wellness. This trend is supporting the demand for wearable technologies capable of tracking a range of health parameters.
• In addition, expanding smartphone penetration, improving internet connectivity, and greater exposure to digital health applications are increasing consumer familiarity with wearable devices across the region. Governments, healthcare organizations, and fitness initiatives are also promoting healthier lifestyles and regular health monitoring. As a result, the adoption of clinical-grade wearables is increasing across both personal wellness and healthcare settings, contributing to the growth of the Middle East & Africa clinical-grade wearables market.

Clinical Grade Wearables Market Share

• The leading players in the clinical-grade wearables industry include Abbott Laboratories, Dexcom, Medtronic, Koninklijke Philips N.V., and Masimo, which together account for an estimated 60% of the global market share. These companies benefit from strong expertise in patient monitoring technologies, continuous product innovation, extensive clinical validation, and well-established global distribution networks. Their broad portfolios spanning continuous glucose monitoring, remote patient monitoring, cardiac monitoring, and biosensor-based wearable solutions position them as key market participants, while the remaining market is characterized by the presence of regional, emerging, and niche wearable technology providers serving specific clinical and healthcare applications.
• Leading clinical-grade wearable manufacturers are increasingly prioritizing technological innovation, clinical accuracy, and user-centric device design to enhance patient monitoring and healthcare outcomes. Key focus areas include advanced biosensors, real-time physiological monitoring, artificial intelligence-enabled analytics, wireless connectivity, and extended battery life to support continuous health tracking across diverse care settings. Additionally, companies are investing in integrated digital health ecosystems, including cloud-based platforms, remote patient monitoring solutions, and interoperable healthcare systems, to improve clinical workflows and data-driven decision-making across hospitals, outpatient facilities, and home healthcare environments.
• Healthcare providers and wearable technology companies are strengthening strategic collaborations with hospitals, research institutions, digital health platform providers, and healthcare technology developers to accelerate the adoption of next-generation clinical-grade wearables. These partnerships support clinical validation, product development, regulatory compliance, and integration with healthcare infrastructure. Such alliances also facilitate broader deployment of wearable monitoring solutions, enhance care coordination, and improve patient engagement across acute care, chronic disease management, and remote monitoring programs.
• Market participants in emerging and cost-sensitive regions are focusing on affordability, scalable deployment models, and localized commercialization strategies to expand access to clinical-grade wearable technologies.

Clinical Grade Wearables Market Companies

A few of the prominent players operating in the clinical grade wearables industry include:

• Abbott Laboratories
• BioIntelliSense
• Biobeat
• Boston Scientific Corporation
• Dexcom
• Empatica  
• iRhythm Technologies
• LifeSignals
• Masimo
• Omron Healthcare
• Philips
• Sotera Wireless

• VitalConnect
• Withings
• Medtronic
• Medtronic is a key contributor to the clinical-grade wearables market through its integrated monitoring solutions and diabetes care technologies, supported by extensive clinical expertise and a strong presence across global healthcare systems

• KoninKlijke Philips N.V.

Koninklijke Philips N.V. is a prominent participant in the clinical-grade wearables market, leveraging its expertise in connected care, remote patient monitoring, and digital health technologies to support clinical decision-making and patient management.

• Masimo

Masimo is a well-established player in the clinical-grade wearables market, driven by its innovative biosensor technologies and noninvasive monitoring solutions that enable continuous tracking of vital health parameters across care settings

Clinical Grade Wearables Industry News:

• In February 2025, BioIntelliSense announced a strategic partnership with Hicuity Health to integrate its FDA cleared BioButton wearable and BioDashboard clinical intelligence platform with Hicuity Health's virtual patient monitoring services. This collaboration is expected to expand scalable continuous patient monitoring across hospitals, hospital-at-home programs, post discharge care, and chronic disease management, thereby strengthening the company's presence in the clinical-grade wearables market.

The global clinical grade wearables market research report includes an in-depth coverage of the industry with estimates and forecasts in terms of revenue in (USD Million) from 2022 - 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Devices

• Activity/fitness monitors 

• Diabetes devices 

• Cardiac monitors 

• Neurological monitors 

• Respiratory monitors 

• Body & temperature monitors 

• In-ear device

• Other devices

Market, By Application

• Cardiac health

• Obesity control

• Diabetes care

• Fitness monitoring

• Sleep tracking

• Other applications 

Market, By End Use

• Hospitals

• Home care settings

• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE